Genetic Signatures logo

GSS - Genetic Signatures Share Price

A$1.12 0.0  0.0%

Last Trade - 20/10/19

Sector
Healthcare
Size
Small Cap
Market Cap £61.6m
Enterprise Value £58.2m
Revenue £3.80m
Position in Universe 628th / 1837
Bullish
Bearish
Unlock GSS Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

GSS Revenue Unlock GSS Revenue

Net Income

GSS Net Income Unlock GSS Revenue

Normalised EPS

GSS Normalised EPS Unlock GSS Revenue

PE Ratio Range

GSS PE Ratio Range Unlock GSS Revenue

Dividend Yield Range

GSS Dividend Yield Range Unlock GSS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
GSS EPS Forecasts Unlock GSS Revenue
Profile Summary

Genetic Signatures Limited is a molecular diagnostics company. The Company is engaged in the research and commercialization of identifying individual genetic signature to identify diseases and disabilities, and the sale of associated products into diagnostic and research market place. It is focused on the development and commercialization of its platform technology, 3Base. The Company has a suite of polymerase chain reaction (PCR)-based products for the detection of infectious diseases under the EasyScreen brand. Its product portfolio includes EasyScreen detection kits and MethylEasy research kits. The Company's 3base technology forms the basis of its EasyScreen Pathogen Detection Kits. Its EasyScreen products provide hospital and pathology laboratories with the molecular tools to screen for an array of infectious pathogens. Its MethylEasy research kits include Methyl Easy Xceed, which is a bisulfite modification research kit for the detection of methylation patterns in genes.

Directors
Last Annual June 30th, 2019
Last Interim June 30th, 2019
Incorporated February 15, 2001
Public Since March 31, 2015
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 104,034,437
Free Float (0.0%)
Eligible for
ISAs
SIPPs
GSS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for GSS
Upcoming Events for GSS
Friday 29th November, 2019 Estimate
Genetic Signatures Ltd Annual Shareholders Meeting
Similar to GSS
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.